Bartlomiej Kalaska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

ACS applied materials & interfaces

International journal of molecular sciences

Pharmaceutics

Journal of clinical medicine

Medical University of Bialystok

Medical University of Bialystok (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Bialystok

Poland

Assistant Professor :: Departament of Pharmacodynamics

Education History

Medical University of Bialystok

Poland

PHD :: Department of Pharmacodynamics

Medical University of Bialystok

Poland

MSC :: Faculty of Pharmacy with the Division of Medical Analytics

Publications

Altangerel Amarjargal, Zahra Moazzami Goudarzi, Olga Cegielska, Arkadiusz Gradys, Dorota Kolbuk, Bartlomiej Kalaska, Anna Ruszczyńska, Paweł Ł Sajkiewicz
A facile one-stone-two-birds strategy for fabricating multifunctional 3D nanofibrous scaffolds. Biomaterials science (2023)
Magdalena Skóra, Magdalena Obłoza, Małgorzata Tymecka, Bartlomiej Kalaska, Magdalena Gurgul, Kamil Kaminski
Studies on Antifungal Properties of Methacrylamido Propyl Trimethyl Ammonium Chloride Polycations and Their Toxicity In Vitro . Microbiology spectrum (2023)
Altangerel Amarjargal, Olga Cegielska, Dorota Kolbuk, Bartlomiej Kalaska, Paweł Ł Sajkiewicz
On-Demand Sequential Release of Dual Drug from pH-Responsive Electrospun Janus Nanofiber Membranes toward Wound Healing and Infection Control. ACS applied materials & interfaces (2023)
Altangerel Amarjargal, Olga Cegielska, Dorota Kolbuk, Bartlomiej Kalaska, Paweł Ł Sajkiewicz
On-Demand Sequential Release of Dual Drug from pH-Responsive Electrospun Janus Nanofiber Membranes toward Wound Healing and Infection Control. ACS applied materials & interfaces 16 (1) (2023)
Altangerel Amarjargal, Olga Cegielska, Dorota Kolbuk, Bartlomiej Kalaska, Paweł Ł Sajkiewicz
On-Demand Sequential Release of Dual Drug from pH-Responsive Electrospun Janus Nanofiber Membranes toward Wound Healing and Infection Control. ACS applied materials & interfaces 16 (1) (2023)
Aleksandra Jakimczuk, Bartlomiej Kalaska, Kamil Kaminski, Joanna Miklosz, Shin-Ichi Yusa, Dariusz Pawlak, Krzysztof Szczubiałka, Andrzej Mogielnicki
Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. Journal of clinical medicine 11 (8) (2022)
Joanna Miklosz, Bartlomiej Kalaska, Stanislaw Zajaczkowski, Dariusz Pawlak, Andrzej Mogielnicki
Monitoring of Cardiorespiratory Parameters in Rats-Validation Based on Pharmacological Stimulation. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Justyna Swieton, Joanna Miklosz, Shin-Ichi Yusa, Krzysztof Szczubiałka, Dariusz Pawlak, Andrzej Mogielnicki, Bartlomiej Kalaska
Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice. International journal of molecular sciences 22 (20) (2021)
Joanna Miklosz, Bartlomiej Kalaska, Piotr Podlasz, Małgorzata Chmielewska-Krzesińska, Miłosz Andrzej Zajączkowski, Adam Kosiński, Dariusz Pawlak, Andrzej Mogielnicki
Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models. Pharmaceutics 13 (3) (2021)
Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak
Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer. Pharmaceutics 13 (8) (2021)
Bartlomiej Kalaska, Joanna Miklosz, Kamil Kaminski, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka, Andrzej Mogielnicki
Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats. The Journal of pharmacology and experimental therapeutics 373 (1) (2020)
Adrian Mor, Krystyna Pawlak, Bartlomiej Kalaska, Tomasz Domaniewski, Beata Sieklucka, Marta Zieminska, Bogdan Cylwik, Dariusz Pawlak
Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401. International journal of molecular sciences 21 (17) (2020)
Joanna Miklosz, Bartlomiej Kalaska, Kamil Kaminski, Malgorzata Rusak, Krzysztof Szczubiałka, Maria Nowakowska, Dariusz Pawlak, Andrzej Mogielnicki
The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents. Marine drugs 17 (9) (2019)
Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Bogdan Musielak, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka, Andrzej Mogielnicki
The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target. RSC advances 9 (6) (2019)
Bartlomiej Kalaska, Kamil Kamiński, Joanna Miklosz, Keita Nakai, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Andrzej Mogielnicki, Krzysztof Szczubiałka
Anticoagulant Properties of Poly(sodium 2-(acrylamido)-2-methylpropanesulfonate)-Based Di- and Triblock Polymers. Biomacromolecules 19 (7) (2018)

Bartlomiej Kalaska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bartlomiej Kalaska